Slower, steadier improvements in blood sugar give the retina more time to adapt, which is why some doctors aim for a gradual decline in A1C rather than an abrupt one
Patients who already qualify for GLP-1 therapy and would like additional support Individuals with suboptimal B12 levels or risk of deficiency Those who prefer combining metabolic and micronutrient therapy Patients fully committed to close medical oversight and follow-up However, its not recommended if you have contraindications to GLP-1 agents, are pregnant, breastfeeding, have uncontrolled GI disease, or cannot adhere to monitoring and follow-up
If something feels off at week three, you can reach us
Scientific evidence suggests that these mechanisms may be at least partially overlapping with those regulating food craving and food seeking, he says
At minimum, check metabolic panels, liver function, lipid profiles, and fasting glucose before starting and every 8-12 weeks during combination therapy